Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Lung Neoplasms × aumolertinib × Clear all

Phase

Status

Unknown 8 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 1

Interventions

pembrolizumab 29 Carboplatin 25 durvalumab 21 Specimen Handling 21 Pemetrexed 18 Paclitaxel 16 Cisplatin 16 atezolizumab 15 Magnetic Resonance Spectroscopy 15 Nivolumab 14 osimertinib 13 Radiosurgery 12 Docetaxel 11 Immunoglobulin G 10 Disulfides 10 Radiotherapy 9 Radiation 9 Gemcitabine 9 Taxes 8 Etoposide 8 Biopsy 8 Standard of Care 6 Practice Guidelines as Topic 6 Platinum 6 Ipilimumab 6 Bevacizumab 6 Surveys and Questionnaires 5 Blood Specimen Collection 5 1,2-diaminocyclohexaneplatinum II citrate 5 ceralasertib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04808752 2024-04-22

ACHIEVE

Zhejiang Cancer Hospital

Phase 2 Active not recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡